Treatment CANCER CARE: THE ROLE OF NK CELL THERAPY

CANCER CARE: THE ROLE OF NK CELL THERAPY

Book an appointment

Welcome to our comprehensive guide on cancer treatment, where we delve into the intricacies of current approaches and spotlight the innovative treatment approach of NK cell therapy.

UNDERSTANDING CANCER
Cancer is a complex and diverse group of diseases characterised by the uncontrolled growth and spread of abnormal cells. These cells can form tumours or interfere with the normal functioning of organs, impacting the body’s ability to perform essential functions.

SYMPTOMS

The symptoms of cancer can manifest in various ways, depending on the type, location, and stage of the disease. Some common symptoms include:

• Unexplained Weight Loss: A sudden and unexplained drop in weight, often indicative of the body’s energy resources being redirected to support the rapid growth of cancer cells.

• Persistent Fatigue: Ongoing and extreme tiredness that does not improve with rest, often a result of the body’s immune system working tirelessly to combat the disease.

• Changes in Skin or Moles: Alterations in the size, shape, or colour of moles or other skin abnormalities, which can be indicative of skin cancers.

• Unusual Bleeding or Bruising: Abnormal bleeding, such as frequent nosebleeds or easy bruising, suggesting potential issues with blood clotting and platelet function.

CURRENT TREATMENTS

Conventional cancer treatments aim to eradicate cancer cells, and these approaches can be tailored to the specific type and stage of cancer. Some examples include:

Surgery:
• Lumpectomy/Mastectomy: Surgical removal of a portion (lumpectomy) or the entire breast (mastectomy) in breast cancer cases.
• Hysterectomy: Removal of the uterus, often performed in cases of uterine cancer.

Chemotherapy:
• Paclitaxel (Taxol): A chemotherapy drug that interferes with the growth and division of cancer cells.
• Cisplatin: Used for various cancers, it works by interfering with the DNA inside cancer cells.

Radiation Therapy:
• External Beam Radiation: Precise targeting of cancer cells using high-dose radiation from outside the body.
• Brachytherapy: Internal radiation therapy involving the placement of a radioactive source directly inside or next to the tumour.

Immunotherapy:
• Pembrolizumab (Keytruda): An immune checkpoint inhibitor that helps the immune system recognise and attack cancer cells.
• Nivolumab (Opdivo): Another checkpoint inhibitor that enhances the immune response against cancer.

Targeted Therapies:
• Gleevec (Imatinib): Used for certain types of leukaemia and gastrointestinal stromal tumours (GISTs), targeting specific molecules involved in cancer cell growth.
• Herceptin (Trastuzumab): Designed for breast cancers that overexpress the HER2 protein.

NK CELL THERAPY: A CUTTING-EDGE INTERVENTION

At the heart of NK cell therapy lies the unique capability of natural killer (NK) cells to target and destroy cancer cells. Sourced from the patient’s own body or a donor, NK cells play a vital role in immune surveillance and response.

THE SCIENTIFIC MECHANISMS
NK cell therapy involves isolating, activating, and infusing NK cells into the patient’s body. These cells, known for their innate ability to recognise and eliminate abnormal cells, enhance the body’s natural defence against cancer.

NK cells exhibit potent cytotoxic effects, directly attacking and destroying cancer cells. This targeted approach aims not only to manage symptoms but to address the root cause by eliminating cancer cells at their source.

Beyond direct cell killing, NK cells stimulate the overall immune response. By modulating the inflammatory environment and promoting immune memory, NK cell therapy offers a comprehensive and adaptive strategy in the fight against cancer.

MULTI-FACETED BENEFITS

• Targeted Cancer Cell Destruction: Enhances the body’s ability to identify and eliminate cancerous cells.

• Immune Stimulation: Boosts the overall immune response, creating a sustained defence against cancer.

• Inflammatory Modulation: NK cells contribute to a balanced inflammatory environment conducive to healing.

• Holistic Approach: Addresses not only the physical symptoms but also the emotional and mental aspects of the cancer journey.

CLINICAL EFFICACY
Clinical outcomes with NK cell therapy can vary. Some patients experience significant improvements shortly after treatment, while others observe gradual progress over time. The nuanced nature of these responses emphasises the need for personalised care and ongoing monitoring.

NK CELL THERAPY AT KANTSUGI

Behind this innovative approach is our expert team of international doctors and collaborative research at Kantsugi. Rooted in medical expertise and guided by our values, we are committed to cutting-edge advancements in cancer care, weaving together the principles of regenerative medicine and the fundamentals of patient-centric care.

WHAT TO EXPECT – PERSONALISED CANCER CARE:
• Tailored treatment plans designed for individual needs.
• Thorough assessment of medical history and symptoms.
• Utilisation of the latest advancements in NK cell therapy.
• Beyond symptom management, a focus on overall well-being.

CONSULTATION PROCESS
Our experienced team of medical professionals will conduct a thorough assessment, considering the unique medical history and symptoms of each patient. This in-depth consultation aims to tailor the NK cell therapy approach to individual needs.

TREATMENT DURATION
The duration of NK cell therapy for cancer patients can vary. While some individuals may experience immediate improvements shortly after treatment, others may observe gradual progress over an extended period. This variability underlines the importance of ongoing monitoring and personalised care to ensure the most effective and beneficial outcomes.

FOR EXPERTS: RESEARCH AND WHITE PAPERS
For experts in the field seeking more information on current research and white papers related to NK cell therapy for cancer, please visit our Research and Publications section. Stay informed about the latest advancements and scientific insights in regenerative medicine.